| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/19/2001 | EP1163327A1 Human protein kinase b gamma polypeptides and a method for disrupting protein kinase b gamma in a non-human |
| 12/19/2001 | EP1163272A1 Antibodies specific for cyp1b1 |
| 12/19/2001 | EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
| 12/19/2001 | EP1163270A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods |
| 12/19/2001 | EP1163267A1 47 human secreted proteins |
| 12/19/2001 | EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 12/19/2001 | EP1163255A1 50 human secreted proteins |
| 12/19/2001 | EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 12/19/2001 | EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 12/19/2001 | EP1163049A1 Method for producing a matrix of sequences of chemical or biological molecules for a chemical or biological analysis device |
| 12/19/2001 | EP1162997A2 Staphylococcus antigen and vaccine |
| 12/19/2001 | EP1162994A1 A means for the prophylactic and therapeutic treatment of streptococcal infections |
| 12/19/2001 | EP1162993A2 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 12/19/2001 | EP1162961A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 12/19/2001 | EP1162886A1 System and method for evaluating agents which prevent oxidative damage |
| 12/19/2001 | EP1162880A1 Human sperm surface antigens |
| 12/19/2001 | EP1162879A2 Synthesis of the first paramagnetic and active analogue (epm-2) of the melanocyte stimulating hormone containing amino acid-type stable free radical |
| 12/19/2001 | EP1114177A4 Assay member and method for its manufacture |
| 12/19/2001 | EP1075551B1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 12/19/2001 | EP1051622A4 PAI-2 AND t-PA AS DIAGNOSTIC MARKERS OF PERIODONTAL DISEASE |
| 12/19/2001 | EP0990131A4 Moisture analyzer |
| 12/19/2001 | EP0948639A4 Identification of blast cells in a leukocyte cell preparation |
| 12/19/2001 | EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 12/19/2001 | EP0925494B1 A micro flow system for particle separation and analysis |
| 12/19/2001 | EP0871777A4 Electronically-solid-phase assay biomolecules |
| 12/19/2001 | EP0864000A4 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 12/19/2001 | EP0727045B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 12/19/2001 | EP0711341A4 Receptor function assays |
| 12/19/2001 | EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 12/19/2001 | EP0586573B1 Endotoxin binding and neutralizing protein and uses thereof |
| 12/19/2001 | EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 12/19/2001 | CN1327538A Immune chromatographic test piece and chromatographic analysis method |
| 12/19/2001 | CN1327536A 葡萄糖传感器 The glucose sensor |
| 12/19/2001 | CN1327389A Coupling factor 6 inhibitor and potentiator and use thereof |
| 12/19/2001 | CN1327388A Modified antibodies of induced anti-idiotype reaction enhancement |
| 12/19/2001 | CN1327159A Immune analysis method, reagent and device for detecting saccharified protein |
| 12/19/2001 | CN1327158A Establishment of anti-morphine single anti-cell strain and method for producing double-side morphine test paper |
| 12/19/2001 | CN1327070A Diagnosis method based on nucleic acid having catalytic activity |
| 12/19/2001 | CN1076476C Karl Fischer Moisture determination instrument |
| 12/19/2001 | CN1076474C Device and method for evaluating crystallization |
| 12/18/2001 | US6332110 Method for monitoring advanced separation and/or ion exchange processes |
| 12/18/2001 | US6331704 Hydraulic fluid contamination monitor |
| 12/18/2001 | US6331618 For analytical methods such as gel electrophoresis, high-performance liquid chromatography, primer extension reactions, polymerase chain reaction (pcr), mass spectroscopy, nuclear magnetic resonance (nmr) and x-ray crystallization |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331441 For high throughput analysis of multiple analytes in complex mixtures of sample substances, combinatorial analysis |
| 12/18/2001 | US6331440 Peptide binding the KLVFF-sequence of amyloid-β |
| 12/18/2001 | US6331436 Injecting tracer containing fluid at first point and analyzing at least one sample from a second point in the flow of the fluid for the tracer compound |
| 12/18/2001 | US6331435 Providing a synthetic erythrocyte sedimentation rate (esr) control capable of producing measured esr values within a predictable range; providing an erythrocyte sedimentation rate test apparatus; performing esr determination; comparing |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
| 12/18/2001 | US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity |
| 12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
| 12/18/2001 | US6331411 TopA |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331408 Contacting a potential inhibitor of beta-amyloid production and tagged inhibitor of beta-amyloid production with at macromolecule involved in processing of amyloid precursor protein; separating tagged inhibitor, determining |
| 12/18/2001 | US6331406 Human enbryonic germ cell and methods of use |
| 12/18/2001 | US6331405 Detection of modulators of laminin binding; incubate microorganism polypeptide with modulator, detect bound complex, the absence of binding to laminin receptor indicates bound complex |
| 12/18/2001 | US6331402 Detecting preferential particle in sample; form testing mix, incubate with sample, monitor sample for presence of preferential particle, binding indicates presence of partical |
| 12/18/2001 | US6331400 Binding sites of binding proteins and their binding partners are characterized, at individual amino acid level, by a tritium exchange labeling and sequential degradation and analysis of tritiated fragments under slowed exchange |
| 12/18/2001 | US6331398 Nucleic acid ligands |
| 12/18/2001 | US6331395 Prenatal diagnostic methods |
| 12/18/2001 | US6331393 Detecting cytosine methylation and methylated cytosine/guanine aggregations; incubate genomic nucleotide sequences adjusting agent, amplify nucleotide sequences, detecting the methylated nucleotide sequences |
| 12/18/2001 | US6331390 Cell-cycle regulatory proteins, and uses related thereto |
| 12/18/2001 | US6331301 Isolated dna sequences which encodes amino acid sequence in protein; |
| 12/18/2001 | US6331277 Sucking, discharging a liquid |
| 12/18/2001 | US6331276 Flat substrate and a layer of insulating beads of a polymer or non-metal arranged uniformly; free electron thin metal microparticle layer; highly sensitive to change in the reflection spectrum of metal microparticles present on a metal |
| 12/18/2001 | US6331275 Spatially addressable, cleavable reflective signal elements, assay device and method |
| 12/18/2001 | US6331244 Sensors for detecting analytes in fluids |
| 12/18/2001 | US6331175 Method and kit for imaging and treating organs and tissues |
| 12/18/2001 | US6330934 Complete fluid exchange system for automatic transmissions |
| 12/18/2001 | US6330834 Liquid sampling tool |
| 12/18/2001 | US6330819 Method and apparatus for calibrating a dissolved oxygen analyzer |
| 12/18/2001 | CA2218483C Microspheres with fluorescent spherical zones |
| 12/18/2001 | CA2210559C Analytical system with means for detecting too small sample volumes |
| 12/18/2001 | CA2179281C Methods of identifying lymphocytes with mutator phenotypes |
| 12/18/2001 | CA2134478C Microfabricated detection structures |
| 12/18/2001 | CA2126296C Diagnostic circuit and method for amperometrically determining the current passing through a sensor |
| 12/18/2001 | CA2125004C Simultaneous amplification of multiple targets |
| 12/18/2001 | CA2067394C Enzyme amplified lanthanide chelate luminescence assay |
| 12/18/2001 | CA2026617C Method and apparatus for measuring multiple optical properties of biological specimens |
| 12/14/2001 | CA2350341A1 Method and system for predicting pharmacokinetic properties |
| 12/13/2001 | WO2001095281A1 Leak detector |
| 12/13/2001 | WO2001095233A2 Analysis of data from liquid chromatographic separation of dna |
| 12/13/2001 | WO2001095230A2 Method for predicting therapeutic agent resistance using neural networks |
| 12/13/2001 | WO2001095059A2 A method and system for populating a database |
| 12/13/2001 | WO2001094952A2 Methods and compositions for modulating oxidized ldl transport |
| 12/13/2001 | WO2001094951A2 Inhibitors of c-reactive protein induced inflammation |
| 12/13/2001 | WO2001094949A2 Soluble cd1 compositions and uses thereof |
| 12/13/2001 | WO2001094948A1 Elisa for baculovirus |
| 12/13/2001 | WO2001094947A1 Core-shell metal particles coated with dextran or aminodextran carrying sh groups, and use thereof |
| 12/13/2001 | WO2001094946A2 Microarrays for performing proteomic analyses |
| 12/13/2001 | WO2001094945A2 Method for enhancing the solubility of proteins by alkylating reagents |
| 12/13/2001 | WO2001094944A2 Artificial antigen presenting cells and methods of use thereof |
| 12/13/2001 | WO2001094943A2 Method for determining the quantity of ligands that are bound to target molecules |
| 12/13/2001 | WO2001094942A1 Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient |
| 12/13/2001 | WO2001094941A2 Diagnostic methods for pompe disease and other glycogen storage diseases |
| 12/13/2001 | WO2001094940A1 Method for histocompatibility testing |
| 12/13/2001 | WO2001094938A1 Flow cytometry-based hematology system |
| 12/13/2001 | WO2001094937A1 Integrated water quality monitoring system |